A 0 8
Pill imprint A 0 8 has been identified as Mirtazapine 15 mg.
Mirtazapine is used in the treatment of depression; anxiety; insomnia; hot flashes; post traumatic stress disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy.
Mirtazapine 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Mirtazapine Images
- Imprint:
-
A
0 8 - Strength:
- 15 mg
- Color:
- Yellow
- Size:
- 9.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- corn starch
low substituted hydroxypropyl cellulose
magnesium stearate
silicon dioxide
lactose monohydrate
hypromellose 2910 (6 mPa.s)
titanium dioxide
hydroxypropyl cellulose
ferric oxide yellow
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0031
| NDC Code | Manufacturer / Repackager |
|---|---|
| 64679-0559 | Wockhardt USA |
| 59762-1416 | Greenstone LLC |
| 23490-6989 | Palmetto State Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Mirtazapine resources
- Mirtazapine (Wolters Kluwer)
- Mirtazapine Orally Disintegrating Tablets (Wolters Kluwer)
- mirtazapine (Cerner Multum)
- Remeron RD (Micromedex) - Includes Dosage Information
- mirtazapine (Micromedex) - Includes Dosage Information
- Mirtazapine (AHFS DI)
- Mirtazapine Orally Disintegrating Tablets (FDA)
- Mirtazapine Tablets (FDA)
- Remeron Tablets (FDA)
- Mirtazapine (Wolters Kluwer)
Search Again
